Sigma-Aldrich, Oxford BioMedica and Open Biosystems Settle Patent Dispute Over Use of LentiVector Technology in Research Reagent
Sigma-Aldrich, Oxford BioMedica and Open Biosystems, Inc. have jointly announced a confidential settlement of their patent litigation. Sigma-Aldrich and Oxford BioMedica agreed to dismiss the lawsuit brought against Open Biosystems. Open Biosystems agreed to dismiss its counterclaims in the lawsuit. As part of the settlement Open Biosystems will acquire certain license rights under the Oxford BioMedica patents for use of the LentiVector technology in research activities. Other details of the agreement have not been disclosed.
Most read news
Organizations
Other news from the department business & finance
Get the analytics and lab tech industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Discovery of world’s oldest DNA breaks record by one million years - Two-million-year-old DNA has been identified for the first time - opening a ‘game-changing’ new chapter in the history of evolution
Virus multiplication in 3D
BAM develops certified PFAS reference material made from used outdoor clothing - On the way to a circular economy
Catalytic activity of individual cobalt oxide nanoparticles determined - Using a robotic arm
Exposing what’s in tattoo ink - Ingredient lists often aren’t accurate
Andor Technology plc acquires Photonic Instruments Inc.
Applied Biosystems, Roche Molecular Systems, Bio-Rad, and MJ Research Reach Settlement Agreement Regarding Thermal Cyclers